#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic lupus erythematosus Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Oesophageal adenocarcinoma stage II Palmoplantar pustulosis Anaemia Rectal cancer Microvillous inclusion disease Cutaneous calcification Oesophageal atresia Pneumonia Systemic scleroderma Soft tissue necrosis Pleomorphic liposarcoma Primary adrenal insufficiency Acute myeloid leukaemia recurrent More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Life with Disease Systemic sclerosis pulmonary – Life with Disease Osteosarcoma metastatic – Life with Disease Hereditary hypophosphataemic rickets – Treatment KBG syndrome – Basic Information CADASIL – Trials in Disease Hepatic angiosarcoma – Life with Disease Pemphigus – Trials in Disease Lysosomal storage disorder – Basic Information Aicardi-Goutieres syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Promazine Hydrochloride Gallium (68Ga) Aaa802 GVV858 [18F]Mc225 Solrikitug Ioversol Stro-002 Purified Egg Phospholipids Ads-011 ACT-1004-1239 Gadobutrol Sildenafil Citrate Surzebiclimab ABIRATERONE DECANOATE Zasocitinib Nystatin Urapidil His203-Crm197 Tamuzimod Acetate More therapies…

    Learn about Your Condition

    Pneumonia chlamydial Multifocal motor neuropathy Post procedural complication Atopic keratoconjunctivitis B-cell lymphoma refractory Lung neoplasm malignant Psychotic disorder Venous thrombosis Dyskinesia Kidney transplant rejection Relapsing multiple sclerosis Congenital aplastic anaemia Lymphocyte adoptive therapy Senile dementia Exfoliation glaucoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on MB-CART2219.1 for Adults and Children with Relapsed or Refractory B-cell Malignancies

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • MB-CART2219.1
    Germany

  • Study on Sumatriptan and Rimegepant for Treating Nitroglycerin-Induced Headaches in Patients with Episodic Migraine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Isosorbide Dinitrate
    • SUMATRIPTAN
    • Rimegepant
    Spain

  • Study on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • (S)-2-ETHYL-8-METHYL-1-THIA-4,8-DIAZASPIRO[4.5]DECAN-3-ONE
    • Trospium Chloride
    Austria Czechia Germany Italy

  • Study on [18F]Tetrafluoroborate PET/CT for Detecting Thyroid Cancer in Patients with Differentiated Thyroid Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Thyroid cancer
    The Netherlands

  • Study of ETX-19477 for Patients with Advanced Solid Tumors After Standard Treatment

    Recruiting

    2 1 1
    Investigated Drugs:
    • ETX-19477
    France Italy Spain

  • Study on Encorafenib, Binimetinib, Cemiplimab, and Fianlimab for Patients with BRAF-Mutated Melanoma and Brain Metastases

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    • Binimetinib
    Spain
Previous Page
1 … 234 235 236 237 238 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!